Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q3 FY24 results · Oct–Dec 2023
Divi's Laboratories reported revenue from operations of ₹1,855.00 crore (up 8.6% from Q3 FY23) and net profit of ₹358.00 crore (up 16.7% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,855.00 | 1,707.68 | +8.6% | 1,909.00 | −2.8% |
| Other income | 95.00 | 114.25 | −16.8% | 86.00 | +10.5% |
| Total income | 1,950.00 | 1,821.93 | +7.0% | 1,995.00 | −2.3% |
| Profit before tax | 489.00 | 435.63 | +12.3% | 469.00 | +4.3% |
| Net profit for the period | 358.00 | 306.80 | +16.7% | 348.00 | +2.9% |
| EPS, basic (₹) | 13.50 | 11.56 | +16.8% | 13.11 | +3.0% |
| Net margin (%) | 19.3 | 18.0 | 18.2 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,808.00 | 1,689.83 | +7.0% | 1,868.00 | −3.2% |
| Other income | 94.00 | 116.34 | −19.2% | 85.00 | +10.6% |
| Total income | 1,902.00 | 1,806.17 | +5.3% | 1,953.00 | −2.6% |
| Profit before tax | 490.00 | 439.11 | +11.6% | 464.00 | +5.6% |
| Net profit for the period | 358.00 | 310.90 | +15.1% | 342.00 | +4.7% |
| EPS, basic (₹) | 13.50 | 11.71 | +15.3% | 12.89 | +4.7% |
| Net margin (%) | 19.8 | 18.4 | 18.3 |
Consolidated
- Filed with BSE
- 10 Feb 2024, 17:56 IST
- Board meeting
- 10 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Feb 2024, 17:56 IST
- Board meeting
- 10 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE